DV
Dividend Vision

NVAX — Novavax Inc.

Novavax Inc. (NVAX)

Total return is -89.9% over the past 30.7 years, 2118.1 points behind SPY at 2028.2%. Its deepest 1-year drawdown was 35.9%.

This is a single-stock equity holding in Novavax Inc., a biotechnology company, rather than a diversified ETF. As a concentrated position in a single company, it carries no regular distribution rate or dividend yield, making it unsuitable for income-focused investors. This holding appeals primarily to growth-oriented investors seeking exposure to the biotechnology sector's potential capital appreciation rather than dividend income.

NVAX key facts

Asset type
Stock
Asset class
Equity
Inception date
12/05/1995
Last close
$8.05
Market cap
$1,327,813,120
Average volume
2274600.0
Payment date
05/10/2019
Beta
2.416
Payout ratio
0.0
P/E ratio
3.1124
Forward P/E
2.5846
EPS
$-1.53